The latest version of electron-beam tomography, e-Speed, has been installed at Edward Heart Hospital in Naperville, IL. The hospital is among the first three sites in the world to install the EBT system, which GE Medical Systems acquired through its
The latest version of electron-beam tomography, e-Speed, has been installed at Edward Heart Hospital in Naperville, IL. The hospital is among the first three sites in the world to install the EBT system, which GE Medical Systems acquired through its corporate takeover of Imatron in December 2001 (SCAN 1/2/02). The EBT product is dedicated to cardiology and was introduced last year at the annual meeting of the American Heart Association (SCAN 11/27/03). GE released in mid-May at the annual meeting of the North American Society of Pacing and Electrophysiology a cardiac CT software application dedicated to electrophysiology. The software, called CardEP, includes tools designed to assist the assessment of complex cardiac anatomy. Features include interactive 3D modeling and segmentation.
Shaping the Future of Radiology in 2025: Trends, Threats, and Opportunities
January 10th 2025How do we respond to challenges with staff recruitment, cybersecurity, and looming hospital takeovers in radiology? This author assesses key trends in radiology and offers key insights to stay competitive in the field.
Can MRI Have an Impact with Fertility-Sparing Treatments for Endometrial and Cervical Cancers?
January 9th 2025In a literature review that includes insights from recently issued guidelines from multiple European medical societies, researchers discuss the role of magnetic resonance imaging (MRI) in facilitating appropriate patient selection for fertility-sparing treatments to address early-stage endometrial and cervical cancer.
Surveillance Breast MRI Associated with Lower Risks of Advanced Second Breast Cancers
January 8th 2025After propensity score matching in a study of over 3,000 women with a personal history of breast cancer, researchers found that surveillance breast MRI facilitated a 59 percent lower risk in advanced presentations of second breast cancers.